University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 20 of 23
The LIFE Study - Lifestyle Interventions and Independence for Elders
NCT01072500
The Addition of Whole Grains to the Diets of Middle-school Children
NCT01094652
Village Interactive Training and Learning Study
NCT01709799
Brain Imaging and Pain: Analysis of Placebo Analgesia
NCT01409538
Needs Assessment Evaluating Quality of Life Issues for Gastroparesis Patients and Caregivers
NCT01329211
Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease
NCT01168596
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
NCT01040624
Resveratrol for Improved Performance in the Elderly
NCT01126229
Effects of Milnacipran on Widespread Mechanical and Thermal Hyperalgesia of Fibromyalgia Patients
NCT01294059
Galactooligosaccharide, Immune Strength, and Digestive Health
NCT01137760
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B)
NCT01221129
Sleep and Ventricular Arrhythmias Study
NCT02232204
Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
NCT01135875
Patient Comfort With Vascular Closure
NCT00998023
The Effectiveness of a Mechanical Manual Therapy Device in the Treatment of Neck Pain
NCT01168986
Brain Stimulation for the Treatment of Tourette Syndrome
NCT01329198
The Mechanisms of Manual Therapy in the Treatment of Low Back Pain
NCT01168999
Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)
NCT00875901
Bariatric Surgery on Short Term Weight Loss- Related Changes in Gait
NCT01447316
Pharmacotoxicology of Trichloroethylene Metabolites
NCT00874276
Prospective Evaluation of the Clinical Utility of Endoscopically Placed Self-expandable Stents
NCT00968552
Evaluation of Pancreatic Pseudocyst Drainage With a Metal Stent
NCT01239056
Proton Therapy for Hodgkin Lymphoma
NCT00850200
Functional and Quality of Life Outcomes Following Viscosupplementation for Knee Osteoarthritis
NCT01447303
Fatigue in Dystonia (a Single Session, Questionnaire-based Study of Fatigue in Dystonia)
NCT00954408
Extension Family Lifestyle Intervention Project (E-FLIP for Kids)
NCT01820338
Cognitive Behavioral Effects on Sleep, Pain, and Cytokines in Gynecologic Cancer
NCT02609880
Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)
NCT00881712
Reactions to Contrast Media (CM) Administered at the Time of the Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT00900640
Evaluation of the Use of Metal Stents as Part of the Treatment of Benign Biliary Strictures
NCT01238900
Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study
NCT01099397
RNActive®-Derived Therapeutic Vaccine
NCT00906243
Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma
NCT00901836
Cord Blood Plus Vitamin D and Omega 3s in T1D
NCT00873925
Cranberry Enhances Human Immune Function and Reduces Illness
NCT01398150
PPI and Clopidogrel Response
NCT01170533
Proton Radiation for Resectable Carcinoma of the Pancreas
NCT00763516
Sleep and Pain Interventions in Fibromyalgia
NCT02001077
The Effects of Adding a Home Exercise Program to a Clinical Physical Therapy Program on Cancer-Related Fatigue
NCT00840554
Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder
NCT00382291
Viokase 16, Viokase16 Plus Nexium and Nexium Alone
NCT01142128
Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
NCT01323582
Aspirin Dosing in Diabetic Patients
NCT01201785
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)
NCT00994682
Comparison of Two Types of Biopsy Forceps for Obtaining Cold Biopsy Polypectomy for Small Sessile Colorectal Polyps Less Than 6 mm in Diameter
NCT00855790
Timing of Antibiotic Prophylaxis for Cesarean Deliveries
NCT00805545
Muscle Weakness and Post-traumatic Knee OA
NCT01879852
Observational Study for Subjects With Pompe Disease Undergoing Immune Modulation Therapies
NCT01451879
Lowering Serum Uric Acid to Prevent Acute Kidney Injury
NCT00756964
Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and Neck
NCT00797043
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.